Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
Science (New York, N.Y.)
|
April 27, 1984
Repression of rearranged mu gene and translocated c-myc in mouse 3T3 cells X Burkitt lymphoma cell hybrids
K Nishikura, A ar-Rushdi, J Erikson, et al.
Journal of the American College of Surgeons
|
March 26, 2026
Circulating Factors Induce Cardiomyopathy after Burn Injury
Susana Fortich, Jake J Wen, Jana E Dejesus, et al.
The Journal of Craniofacial Surgery
|
September 29, 2025
Posterior Vault Distraction Osteogenesis: A Systematic Review and Single-Arm Metanalysis
Camila Franco-Mesa, Gabriel De La Cruz Ku, Alen Palackic, et al.
Cell Differentiation
|
December 1, 1984
Activity of X-linked genes in stem and differentiated Mus musculus X Mus caroli hybrid cells
K Huebner, L Nagarajan, E deJesus, et al.
Antimicrobial Agents and Chemotherapy
|
June 1, 1996
Gastrointestinal tract colonization with vancomycin-resistant Enterococcus faecium in an animal model
M S Whitman, P G Pitsakis, E DeJesus, et al.
Journal of Surgical Education
|
August 13, 2025
Standardized Assessment Tool for Surgery Applicants Reduces Attrition and Improves Board Pass Rate
Susana Fortich, Jana E DeJesus, Jaclyn Dempsey, et al.
Melanoma Research
|
August 1, 1997
Melanoma cell lines from different stages of progression and their biological and molecular analyses
K Satyamoorthy, E DeJesus, A J Linnenbach, et al.
The Journal of Antimicrobial Chemotherapy
|
December 17, 2009
Low-abundance HIV species and their impact on mutational profiles in patients with virological failure on once-daily abacavir/lamivudine/zidovudine and tenofovir
L L Ross, E Rouse, P Gerondelis, et al.
Journal of Virology
|
June 1, 1993
Cross-reactive lysis of human targets infected with prototypic and clinical human immunodeficiency virus type 1 (HIV-1) strains by murine anti-HIV-1 IIIB env-specific cytotoxic T lymphocytes
S Chada, C E DeJesus, K Townsend, et al.
HIV Medicine
|
October 24, 2012
Final 192-week efficacy and safety of once-daily darunavir/ritonavir compared with lopinavir/ritonavir in HIV-1-infected treatment-naïve patients in the ARTEMIS trial
C Orkin, E DeJesus, H Khanlou, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
Science (New York, N.Y.)
|
April 27, 1984
Repression of rearranged mu gene and translocated c-myc in mouse 3T3 cells X Burkitt lymphoma cell hybrids
K Nishikura, A ar-Rushdi, J Erikson, et al.
Journal of the American College of Surgeons
|
March 26, 2026
Circulating Factors Induce Cardiomyopathy after Burn Injury
Susana Fortich, Jake J Wen, Jana E Dejesus, et al.
The Journal of Craniofacial Surgery
|
September 29, 2025
Posterior Vault Distraction Osteogenesis: A Systematic Review and Single-Arm Metanalysis
Camila Franco-Mesa, Gabriel De La Cruz Ku, Alen Palackic, et al.
Cell Differentiation
|
December 1, 1984
Activity of X-linked genes in stem and differentiated Mus musculus X Mus caroli hybrid cells
K Huebner, L Nagarajan, E deJesus, et al.
Antimicrobial Agents and Chemotherapy
|
June 1, 1996
Gastrointestinal tract colonization with vancomycin-resistant Enterococcus faecium in an animal model
M S Whitman, P G Pitsakis, E DeJesus, et al.
Journal of Surgical Education
|
August 13, 2025
Standardized Assessment Tool for Surgery Applicants Reduces Attrition and Improves Board Pass Rate
Susana Fortich, Jana E DeJesus, Jaclyn Dempsey, et al.
Melanoma Research
|
August 1, 1997
Melanoma cell lines from different stages of progression and their biological and molecular analyses
K Satyamoorthy, E DeJesus, A J Linnenbach, et al.
The Journal of Antimicrobial Chemotherapy
|
December 17, 2009
Low-abundance HIV species and their impact on mutational profiles in patients with virological failure on once-daily abacavir/lamivudine/zidovudine and tenofovir
L L Ross, E Rouse, P Gerondelis, et al.
Journal of Virology
|
June 1, 1993
Cross-reactive lysis of human targets infected with prototypic and clinical human immunodeficiency virus type 1 (HIV-1) strains by murine anti-HIV-1 IIIB env-specific cytotoxic T lymphocytes
S Chada, C E DeJesus, K Townsend, et al.
HIV Medicine
|
October 24, 2012
Final 192-week efficacy and safety of once-daily darunavir/ritonavir compared with lopinavir/ritonavir in HIV-1-infected treatment-naïve patients in the ARTEMIS trial
C Orkin, E DeJesus, H Khanlou, et al.
Page
of 3